AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19022156
Drug: Statins (3‐hydroxy‐3‐methyl‐glutaryl‐CoA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins (3‐hydroxy‐3‐methyl‐glutaryl‐CoA reductase inhibitors)
Trial: 11032464
Drug: Amisulpride (400-1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (400-1200 mg/d)
Trial: 1940446
Drug: Low-dose UVB
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose UVB exposure
Trial: 30089292
Drug: Electrical acupuncture
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrical acupuncture with oral essential amino acids (EA + AA)
Trial: 30089292
Drug: Oral essential
RxNorm normalized name: Eucalyptus essential oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral essential amino acids alone (AA)
Trial: 16164495
Drug: Midazolam maintenance
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam maintenance dose ranging from 37.5 to 100 microg/kg/h
Trial: 15314976
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with Vepesid and Cisplatin
Trial: 3336380
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg nicotine gum
Trial: 8916629
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg nicotine gum (placebo)
Trial: 24274627
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment differences
Trial: 2008293
Drug: 1% hyaluronan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% hyaluronan (Healon; HYA) instilled once daily for 7 days
Trial: 6998553
Drug: Corynebacterium parvum
RxNorm normalized name: Corynebacterium parvum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corynebacterium parvum immunotherapy
Trial: 7037155
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment alone (Control)
Trial: 1617888
Drug: Surfactant replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant replacement therapy
Trial: 30974433
Drug: Caffeine and
RxNorm normalized name: caffeine and sodium benzoate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine and postnatal steroids
Trial: 27735908
Drug: Serum soluble
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum soluble Fas ligand (sFas-L) levels measured by enzyme immunoassay in patients with poor course of CHF (n=45)
Trial: 27735908
Drug: Serum soluble
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum soluble Fas ligand (sFas-L) levels measured by enzyme immunoassay in patients with favorable course of CHF (n=49)
Trial: 27735908
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of baseline sFas-L levels between CHF patients and control group
Trial: 27735908
Drug: ROC analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ROC analysis of sFas-L levels for cardiovascular risk stratification
Trial: 27735908
Drug: Correlation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correlation of left ventricular (LV) ejection fraction with sFas-L concentrations
Trial: 19067472
Drug: Prulifloxacin 600
RxNorm normalized name: Orbifloxacin
DrugBank: Orbifloxacin (DB11443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin 600 mg once daily for 3 days
Trial: 19067472
Drug: Prulifloxacin 600
RxNorm normalized name: Orbifloxacin
DrugBank: Orbifloxacin (DB11443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin 600 mg single dose
Trial: 19067472
Drug: Prulifloxacin 600
RxNorm normalized name: Orbifloxacin
DrugBank: Orbifloxacin (DB11443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin 600 mg repeated dosing
Trial: 16103328
Drug: 5% imiquimod
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% imiquimod cream applied 3 times a week for 16 weeks
Trial: 12065555
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (cisplatin and continuous-infusion doxorubicin)
Trial: 2533616
Drug: Nafarelin, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin, a gonadotropin releasing hormone analog, dosage and duration not specified.
Trial: 31830347
Drug: TPF (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPF (docetaxel 60 mg/m2, cisplatin 60 mg/m2, 5-FU 750 mg/m2 continuous IV infusion)
Trial: 31830347
Drug: PF (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF (cisplatin 75 mg/m2, 5-FU 750 mg/m2)
Trial: 25426701
Drug: Neutral protamine
RxNorm normalized name: Neutral protamine hagedorn insulin
DrugBank: Neutral Protamine Hagedorn (NPH) insulin (DB18001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral protamine Hagedorn (NPH) insulin
Trial: 28040350
Drug: Overall population
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall population (all insulin regimens)
Trial: 26063677
Drug: Lisdexamfetamine (LDX)
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine (LDX) 40-60 mg/day for 4 weeks
Trial: 19966380
Drug: De Marco
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De Marco Formula (DMF) 15 ml/kg .day i.m. for 10 days, then twice a week until healing or completion of 52 days
Trial: 11697810
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate + 500 mg calcium (n = 8)
Trial: 11697810
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg calcium only (n = 5)
Trial: 9134641
Drug: Heparin bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin bolus during PTCA
Trial: 3130756
Drug: Single-dose cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose cefazolin (1 gm intravenous)
Trial: 3130756
Drug: Three-dose cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three-dose cefazolin (1 gm intravenous followed by two additional doses, 8 hours apart)
Trial: 30027615
Drug: Single-dose cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose cefazolin
Trial: 3130756
Drug: Three-dose cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three-dose cefazolin
Trial: 26681680
Drug: S-1 monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 monotherapy
Trial: 16430743
Drug: OraDisc (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OraDisc (2 mg amlexanox), applied four times a day for 72 hours
Trial: 16430743
Drug: Vehicle patches,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle patches, applied four times a day for 72 hours
Trial: 16430743
Drug: OraDisc (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OraDisc (2 mg amlexanox)
Trial: 15251640
Drug: Strict insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Strict insulin therapy (target glucose range, 80 to 120 mg/dL)
Trial: 11421871
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no octreotide treatment)
Trial: 7870912
Drug: oxiracetam 800
RxNorm normalized name: oxiracetam 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxiracetam 800 mg
Trial: 7870912
Drug: oxiracetam 2400
RxNorm normalized name: oxiracetam
DrugBank: Oxiracetam (DB13601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxiracetam 2400 mg
Trial: 26578119
Drug: Pregabalin 75
RxNorm normalized name: pregabalin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 75 mg administered 1 hour before and 1 hour after surgery
Trial: 22497680
Drug: A priori
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A priori heparin administration (50 IU/kg) immediately after sheath insertion
Trial: 22497680
Drug: Provisional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Provisional heparin use only if radial artery patency could not be maintained, otherwise no heparin given during the procedure, with a bolus of heparin (50 IU/kg) if needed
Trial: 1424183
Drug: Selenium 50
RxNorm normalized name: SELENIUM 50MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium 50 micrograms as selenomethionine administered once daily for 2 months
Trial: 3659581
Drug: Inhaled fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fenoterol
Trial: 2934747
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ipratropium and fenoterol
Trial: 27306219
Drug: Cystine (700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cystine (700 mg) and theanine (280 mg) orally 1 week before and during S-1 chemotherapy for 5 weeks.
Trial: 27306219
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving S-1 chemotherapy without cystine and theanine.
Trial: 18601306
Drug: dexmethylphenidate ER
RxNorm normalized name: dexmethylphenidate Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmethylphenidate ER 20 mg/day
Trial: 15816453
Drug: PEG plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG plus cisapride (10 mg per os thrice per day three days before the procedure and one 10-mg dose on the morning of the procedure)
Trial: 12808585
Drug: Conjoint therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjoint therapy for partners of alcohol abusers
Trial: 12808585
Drug: Assessment of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assessment of patient-treatment matching dimensions
Trial: 12740337
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg once daily
Trial: 28587568
Drug: Collagenase treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagenase treatment
Trial: 11143848
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with very high lipoprotein (a) levels (> 40 mg/dl)
Trial: 6711776
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine hydrochloride bolus followed by continuous morphine infusion at 0.16 mg/hour
Trial: 6711776
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 2.3 +/- 0.6 mg morphine hydrochloride until the end of the operation
Trial: 27526979
Drug: Rifampicin 900
RxNorm normalized name: Rifampicine
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin 900 mg orally
Trial: 27526979
Drug: Rifampicin 600
RxNorm normalized name: Rifampicin 600 mg powder for solution for infusion vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin 600 mg intravenously (i.v.)
Trial: 27526979
Drug: Rifampicin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (all doses)
Trial: 18656091
Drug: Atorvastatin 10mg
RxNorm normalized name: AMLODIPINE 5MG/ATORVASTATIN 10MG TAB
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10mg daily
Trial: 3555050
Drug: Beta-lactam antibiotics
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-lactam antibiotics
Trial: 8891854
Drug: Conventional plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional plus L-dopa treatment
Trial: 27472747
Drug: Structured Approach
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured Approach Therapy (SAT)
Trial: 21971213
Drug: Capsaicin 15
RxNorm normalized name: CAPSAICIN 150 mg in 100000 mg TOPICAL LIQUID [Good Neighbor Pharmacy Capsaicin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin 15 mg (Anesiva 4975) instillation
Trial: 18273636
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment arm
Trial: 20649635
Drug: Rosiglitazone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (8 mg daily)
Trial: 8448974
Drug: Intravenous [14C]omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous [14C]omeprazole 20mg
Trial: 8448974
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution [14C]omeprazole 40mg
Trial: 1385147
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy for BPH
Trial: 1385147
Drug: Drug trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug trial
Trial: 22809684
Drug: Long acting
RxNorm normalized name: Long Acting Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long acting injection (RLAI)
Trial: 1813168
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) and clomiphene
Trial: 6994779
Drug: Methyldopa 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa 1.2 g daily
Trial: 30866859
Drug: Intervention with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention with print educational materials and Fitbit Flex™ and daily text messages
Trial: 8039761
Drug: Erwinia L-asparaginase
RxNorm normalized name: Erwinia L-asparaginase
DrugBank: Asparaginase Erwinia chrysanthemi (DB08886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erwinia L-asparaginase
Trial: 8039761
Drug: E. Coli
RxNorm normalized name: E. coli antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E. Coli L-asparaginase
Trial: 24564266
Drug: Fentanyl (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (50 μg/ml) at an infusion rate of 0.1 μg/kg/min with bolus doses of 1 μg/kg and a 5‐min lockout time
Trial: 27808555
Drug: Baclofen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (30 mg/day)
Trial: 26713528
Drug: Low-dose UTI
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose UTI (8000 U/kg i.v.)
Trial: 26713528
Drug: High-dose UTI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose UTI and Low-dose UTI
Trial: 11708572
Drug: paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: paracetamol 500 mg plus hyoscine N‐butylbromide 10 mg
Trial: 12706495
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (INO) at 20 ppm
Trial: 23932307
Drug: IUI at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IUI at 34‐36 h after hCG injection (group I, n=106)
Trial: 23932307
Drug: IUI simultaneously
RxNorm normalized name: Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways
DrugBank: Acazicolcept (DB18410)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IUI simultaneously with hCG administration (group II, n=98)
Trial: 20736941
Drug: Chronic low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Chronic low-dose zinc exposure
Trial: 20736941
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of ZnCl2
Trial: 12848630
Drug: Once-daily: placebo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily: placebo, clarithromycin 500 mg and tinidazole 1000 mg
Trial: 1756692
Drug: Iopamidol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol (0.8 osmol/kg; mean dosage 154 +/- 78 ml or 2.1 +/- 1.0 ml/kg)
Trial: 6200729
Drug: Propranolol (0.0125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.0125 to 0.15 mg/kg)
Trial: 28658026
Drug: 250 mL/min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL/min
Trial: 25436797
Drug: Chemotherapy (Pemetrexed)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Pemetrexed)
Trial: 25436797
Drug: Chemotherapy (Docetaxel)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Docetaxel)
Trial: 15977092
Drug: Oral rofecoxib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rofecoxib 50 mg 1 h before surgery plus intraarticular 0.5 % bupivacaine 20 ml postoperatively
Trial: 15977092
Drug: Intraarticular 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular 0.5 % bupivacaine 20 ml postoperatively
Trial: 15977092
Drug: Saline 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline 20 ml intraarticularly after surgery
Trial: 12681866
Drug: 28-day cycles
RxNorm normalized name: desogestrel
DrugBank: Desogestrel (DB00304)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 28-day cycles (21 active pills and a pill-free week)
Trial: 10640841
Drug: Corticosteroid cream
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid cream (clobetasone butyrate 0.05%)
Trial: 30315239
Drug: ibrutinib (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibrutinib (420 mg daily) + bendamustine and rituximab (BR)
Trial: 10921154
Drug: Weinaian capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weinaian capsule (oral administration)
Trial: 7038656
Drug: Once-daily metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily metoprolol
Trial: 7038656
Drug: Twice-daily metoprolol
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily metoprolol
Trial: 20716629
Drug: Post-treatment Ki-67
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment Ki-67 in the third quartile (20%-29%)
Trial: 16938752
Drug: Aerosolized rhDNase
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolized rhDNase (Pulmozyme) 2(1/2) mg once daily
Trial: 16938752
Drug: No rhDNase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No rhDNase treatment (control group)
Trial: 8382419
Drug: Live oral
RxNorm normalized name: Cholera Vaccine Live Oral
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live oral candidate rotavirus vaccines (RIT 4237, RRV‐1, DxRRV, DS1xRRV)
Trial: 16702582
Drug: Twice-a-week weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-a-week weight training for 6 months
Trial: 11391583
Drug: Paclitaxel 60
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 60 mg/m2 and estramustine 900 mg/m2 (Cohort II)
Trial: 9493121
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 4-16 mg once a day
Trial: 9493121
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil in combination with amlodipine or hydrochlorothiazide
Trial: 2038782
Drug: Papaverine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Papaverine (60 mg)
Trial: 31513839
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g E. angustifolia whole fruit powder
Trial: 25939657
Drug: Daily 81
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daily 81 mg aspirin for 14 days before exercise and a single dose of 325 mg aspirin immediately after exertion
Trial: 25939657
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin before exertion
Trial: 25939657
Drug: Single-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose aspirin after exertion
Trial: 18490865
Drug: Carraguard vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carraguard vaginal gel
Trial: 15951127
Drug: Two-part treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-part treatment intervention aimed to reduce long-term benzodiazepine use
Trial: 9259652
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg aspirin
Trial: 3614964
Drug: Buprenorphine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.3 mg in 10 ml glucose solution)
Trial: 3614964
Drug: Morphine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (3 mg in 10 ml glucose solution)